Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Gastroenterology,General Medicine
Reference35 articles.
1. Hepatitis B Virus Infection
2. Natural history of hepatitis B
3. Natural history and prognostic factors for chronic hepatitis type B.
4. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
5. Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel model based on serum N‐glycan markers for evaluating stage of liver necroinflammation in treatment‐naïve chronic hepatitis B patients;Journal of Medical Virology;2024-08
2. Serum N-Glycan Markers for Diagnosing Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels;Engineering;2023-07
3. Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment;Frontiers in Cellular and Infection Microbiology;2023-06-16
4. Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation;The Lancet Regional Health - Western Pacific;2023-06
5. The different prognosis of hepatocellular carcinoma with previous tenofovir vs entecavir treatment for chronic hepatitis B virus: analysis based on 15 propensity score–matched studies;Digestive Diseases;2022-12-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3